These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21527498)

  • 1. Expanding the paradigm for estrogen receptor binding and transcriptional activation.
    Joshi SR; Ghattamaneni RB; Scovell WM
    Mol Endocrinol; 2011 Jun; 25(6):980-94. PubMed ID: 21527498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity.
    Das D; Peterson RC; Scovell WM
    Mol Endocrinol; 2004 Nov; 18(11):2616-32. PubMed ID: 15256536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical approach to predict the affinity of estrogen receptors alpha and beta binding to DNA.
    Tyulmenkov VV; Klinge CM
    Mol Cell Endocrinol; 2001 Aug; 182(1):109-19. PubMed ID: 11500244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.
    Klinge CM; Bodenner DL; Desai D; Niles RM; Traish AM
    Nucleic Acids Res; 1997 May; 25(10):1903-12. PubMed ID: 9115356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasticity of estrogen receptor-DNA complexes: binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers.
    El Marzouk S; Gahattamaneni R; Joshi SR; Scovell WM
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):186-95. PubMed ID: 18479910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro.
    Klinge CM; Peale FV; Hilf R; Bambara RA; Zain S
    Cancer Res; 1992 Mar; 52(5):1073-81. PubMed ID: 1737365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements.
    Tyulmenkov VV; Jernigan SC; Klinge CM
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):151-61. PubMed ID: 10940493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
    Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.
    Verrier CS; Roodi N; Yee CJ; Bailey LR; Jensen RA; Bustin M; Parl FF
    Mol Endocrinol; 1997 Jul; 11(8):1009-19. PubMed ID: 9212049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
    Nardulli AM; Romine LE; Carpo C; Greene GL; Rainish B
    Mol Endocrinol; 1996 Jun; 10(6):694-704. PubMed ID: 8776729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
    Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
    Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
    Wood JR; Likhite VS; Loven MA; Nardulli AM
    Mol Endocrinol; 2001 Jul; 15(7):1114-26. PubMed ID: 11435612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor interaction with estrogen response elements.
    Klinge CM
    Nucleic Acids Res; 2001 Jul; 29(14):2905-19. PubMed ID: 11452016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES).
    Akbas GE; Song J; Taylor HS
    J Mol Biol; 2004 Jul; 340(5):1013-23. PubMed ID: 15236964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE.
    Scott RE; Wu-Peng XS; Yen PM; Chin WW; Pfaff DW
    Mol Endocrinol; 1997 Oct; 11(11):1581-92. PubMed ID: 9328341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.